Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombosis in Diffuse Large B-cell Lymphoma: Impact on Outcome, Evaluation, and Comparison of Predictive Models of Thrombotic Risk: Multicentre Retrospective Observational Study. The PREDIC-TO (PREDICt ThrOmbosis) Study

NCT06694779 is registered in ClinicalTrials.gov with Fondazione IRCCS San Gerardo dei Tintori as lead sponsor.

NCT NCT06694779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06694779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombosis in Diffuse Large B-cell Lymphoma: Impact on Outcome, Evaluation, and Comparison of Predictive Models of Thrombotic Risk: Multicentre Retrospective Observational Study. The PREDIC-TO (PREDICt ThrOmbosis) Study
Lead sponsor
Fondazione IRCCS San Gerardo dei Tintori
Phase
Observational
Overall status
Completed
Start date
May 25, 2023
Completion date
May 25, 2026
Enrollment
1,504 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma, thrombosis